Breast cancer patients develop risk factors. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy10

Breast Cell Line, Tumor Axilla Neoplastic Cells, Circulating Lymph Nodes MCF-7 Cells Tumor Cells, Cultured Mammary Glands, Human Nipples Neoplastic Stem Cells

Organisms1

Diseases45

Breast Neoplasms Carcinoma, Ductal, Breast Neoplasm Metastasis Lymphatic Metastasis Breast Diseases Breast Neoplasms, Male Neoplasms Neoplasm Invasiveness Carcinoma, Lobular Neoplasm Recurrence, Local Genetic Predisposition to Disease Neoplastic Cells, Circulating Carcinoma Carcinoma, Intraductal, Noninfiltrating Lung Neoplasms Disease Progression Ovarian Neoplasms Neoplasms, Hormone-Dependent Bone Neoplasms Carcinoma, Ductal Prostatic Neoplasms Mammary Neoplasms, Experimental Adenocarcinoma Stomach Neoplasms Fibrocystic Breast Disease Colorectal Neoplasms Neoplasms, Second Primary Colonic Neoplasms Triple Negative Breast Neoplasms Carcinoma in Situ Fatigue Bone Marrow Neoplasms Fibroadenoma Lymphedema Neovascularization, Pathologic Cell Transformation, Neoplastic Pancreatic Neoplasms Recurrence Neoplasms, Ductal, Lobular, and Medullary Radiodermatitis Uterine Cervical Neoplasms Endometrial Neoplasms Carcinoma, Non-Small-Cell Lung Carcinoma, Squamous Cell Neoplasms, Multiple Primary

Chemicals and Drugs57

Receptors, Estrogen Receptor, erbB-2 Tamoxifen Tumor Markers, Biological Receptors, Progesterone Antineoplastic Agents, Hormonal Antineoplastic Agents Epirubicin Neoplasm Proteins Aromatase Inhibitors Cyclophosphamide Fluorouracil BRCA2 Protein Estrogen Receptor alpha Anthracyclines Estrogens Estrogen Antagonists BRCA1 Protein Antibodies, Monoclonal, Humanized RNA, Messenger Mucin-1 DNA, Neoplasm Antigens, Neoplasm Nitriles Paclitaxel Antibodies, Monoclonal Estrogen Receptor Modulators Doxorubicin Estradiol Selective Estrogen Receptor Modulators Taxoids Tumor Suppressor Protein p53 Triazoles Ki-67 Antigen Mammaglobin A Methotrexate Receptor, Epidermal Growth Factor Antibiotics, Antineoplastic Keratin-19 Cancer Vaccines RNA, Small Interfering Carcinoembryonic Antigen Tumor Suppressor Proteins RNA, Neoplasm Keratins Antineoplastic Agents, Phytogenic Antigens, CD24 Cisplatin Estrone Deoxycytidine Diphosphonates DNA-Binding Proteins MicroRNAs Transcription Factors Vinblastine Anticarcinogenic Agents Antimetabolites, Antineoplastic

Analytical, Diagnostic and Therapeutic Techniques and Equipment83

Risk Factors Prognosis Neoplasm Staging Chemotherapy, Adjuvant Mastectomy Disease-Free Survival Case-Control Studies Survival Analysis Antineoplastic Combined Chemotherapy Protocols Follow-Up Studies Retrospective Studies Treatment Outcome Mammography Prospective Studies Survival Rate Multivariate Analysis Immunohistochemistry Mastectomy, Segmental Cohort Studies Incidence Risk Assessment Early Detection of Cancer Odds Ratio Risk Predictive Value of Tests Gene Expression Profiling Sentinel Lymph Node Biopsy Kaplan-Meier Estimate Reverse Transcriptase Polymerase Chain Reaction Combined Modality Therapy Sensitivity and Specificity Logistic Models Neoadjuvant Therapy Radiotherapy, Adjuvant Proportional Hazards Models Questionnaires Neoplasm Grading Mammary Neoplasms, Experimental Breast Self-Examination Registries Lymph Node Excision Reproducibility of Results Radiotherapy Drug Administration Schedule Blotting, Western Polymerase Chain Reaction Tissue Array Analysis Tumor Burden Confidence Intervals Oligonucleotide Array Sequence Analysis Mastectomy, Modified Radical SEER Program Immunoenzyme Techniques Ultrasonography, Mammary Xenograft Model Antitumor Assays Prevalence Mammaplasty Clinical Trials as Topic Mastectomy, Radical Neoplasm Transplantation Regression Analysis In Situ Hybridization, Fluorescence Cross-Sectional Studies Pilot Projects Transplantation, Heterologous Mass Screening Genetic Testing Chi-Square Distribution Analysis of Variance Biopsy, Needle DNA Mutational Analysis Enzyme-Linked Immunosorbent Assay Biopsy Body Mass Index Probability Randomized Controlled Trials as Topic Transfection Molecular Targeted Therapy Feasibility Studies ROC Curve Radiotherapy Dosage Breast Implants Drug Screening Assays, Antitumor

Psychiatry and Psychology3

Breast Self-Examination Breast Feeding Smoking

Phenomena and Processes47

Gene Expression Regulation, Neoplastic Postmenopause Genes, BRCA1 Premenopause Genetic Predisposition to Disease Drug Resistance, Neoplasm Time Factors Menopause Odds Ratio Risk Genes, erbB-2 Genes, BRCA2 Sensitivity and Specificity Cell Proliferation Genotype Polymorphism, Genetic Breast Feeding Mutation Germ-Line Mutation Signal Transduction Gene Amplification Apoptosis Dose-Response Relationship, Drug DNA Methylation Cell Movement Polymorphism, Single Nucleotide Cell Division Chi-Square Distribution Alleles Genes, p53 Down-Regulation Promoter Regions, Genetic Genes, Neoplasm Phenotype Up-Regulation Parity Cell Growth Processes Gene Expression Body Mass Index Probability Transfection Cell Cycle RNA Interference Base Sequence Heterozygote Cell Survival Genes, Tumor Suppressor

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena3

Quality of Life Age Distribution Socioeconomic Factors

Humanities1

Quality of Life

Information Science7

Survival Rate Incidence Questionnaires Registries SEER Program Prevalence Base Sequence

Named Groups4

Survivors European Continental Ancestry Group Asian Continental Ancestry Group African Americans

Health Care45

Risk Factors Disease-Free Survival Case-Control Studies Survival Analysis Follow-Up Studies Retrospective Studies Treatment Outcome Prospective Studies Survival Rate Multivariate Analysis Cohort Studies Age Factors Incidence Risk Assessment Odds Ratio Risk Predictive Value of Tests Kaplan-Meier Estimate Sensitivity and Specificity Logistic Models Proportional Hazards Models Questionnaires Registries Reproducibility of Results Confidence Intervals SEER Program Prevalence Clinical Trials as Topic Regression Analysis Cross-Sectional Studies Pilot Projects Mass Screening Genetic Testing Chi-Square Distribution Analysis of Variance Age Distribution Parity Age of Onset Body Mass Index Family Health Probability Randomized Controlled Trials as Topic Socioeconomic Factors Feasibility Studies ROC Curve

Geographicals6

United States China Japan Malaysia Iran Sweden

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Breast Neoplasms Risk Factors Breast Carcinoma, Ductal, Breast Receptors, Estrogen Prognosis Receptor, erbB-2 Tamoxifen Tumor Markers, Biological Receptors, Progesterone Neoplasm Staging Neoplasm Metastasis Chemotherapy, Adjuvant Antineoplastic Agents, Hormonal Cell Line, Tumor Mastectomy Lymphatic Metastasis Gene Expression Regulation, Neoplastic Breast Diseases Breast Neoplasms, Male Disease-Free Survival Case-Control Studies Antineoplastic Agents Neoplasms Survival Analysis Antineoplastic Combined Chemotherapy Protocols Follow-Up Studies Axilla Retrospective Studies Neoplasm Invasiveness Carcinoma, Lobular Treatment Outcome Mammography Prospective Studies Survival Rate Postmenopause Neoplasm Recurrence, Local Multivariate Analysis Immunohistochemistry Epirubicin Neoplasm Proteins Genes, BRCA1 Premenopause Aromatase Inhibitors Mastectomy, Segmental Cohort Studies Genetic Predisposition to Disease Neoplastic Cells, Circulating Carcinoma Age Factors Cyclophosphamide Fluorouracil Incidence Risk Assessment Carcinoma, Intraductal, Noninfiltrating Drug Resistance, Neoplasm Time Factors Lung Neoplasms Menopause Early Detection of Cancer Lymph Nodes Odds Ratio Risk Predictive Value of Tests Disease Progression Gene Expression Profiling Ovarian Neoplasms Neoplasms, Hormone-Dependent Sentinel Lymph Node Biopsy BRCA2 Protein Kaplan-Meier Estimate Bone Neoplasms Genes, erbB-2 Estrogen Receptor alpha Reverse Transcriptase Polymerase Chain Reaction Anthracyclines Combined Modality Therapy Estrogens Estrogen Antagonists BRCA1 Protein MCF-7 Cells Genes, BRCA2 Sensitivity and Specificity Tumor Cells, Cultured Logistic Models Mice, Nude Neoadjuvant Therapy Antibodies, Monoclonal, Humanized Radiotherapy, Adjuvant Survivors Proportional Hazards Models Questionnaires Cell Proliferation RNA, Messenger Mucin-1 DNA, Neoplasm Genotype Carcinoma, Ductal Neoplasm Grading Prostatic Neoplasms

No FAQ available that match "breast cancer patients develop risk factors"